[HTML][HTML] Stem cell-based therapy for human diseases

DM Hoang, PT Pham, TQ Bach, ATL Ngo… - Signal transduction and …, 2022 - nature.com
Recent advancements in stem cell technology open a new door for patients suffering from
diseases and disorders that have yet to be treated. Stem cell-based therapy, including …

[HTML][HTML] Mesenchymal stem cell treatment for COVID-19

R Xu, Z Feng, FS Wang - EBioMedicine, 2022 - thelancet.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has caused a
global pandemic since late 2019 that resulted in more than 360 million population infection …

Hope on the horizon: Wharton's jelly mesenchymal stem cells in the fight against COVID-19

G Gupta, MS Hussain, R Thapa, R Dahiya… - Regenerative …, 2023 - Taylor & Francis
With millions of people infected and hundreds of thousands of fatalities worldwide, the
global health and economies have been greatly affected by the COVID-19 pandemic. The …

Immune responses in mildly versus critically ill COVID-19 patients

H Nasrollahi, AG Talepoor, Z Saleh… - Frontiers in …, 2023 - frontiersin.org
The current coronavirus pandemic (COVID-19), caused by SARS-CoV-2, has had
devastating effects on the global health and economic system. The cellular and molecular …

Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial

CLK Rebelatto, AC Senegaglia, CL Franck… - Stem cell research & …, 2022 - Springer
Background COVID-19 is a multisystem disease that presents acute and persistent
symptoms, the postacute sequelae (PASC). Long-term symptoms may be due to …

SARS-CoV-2 infection and lung regeneration

F Zhao, Q Ma, Q Yue, H Chen - Clinical Microbiology Reviews, 2022 - Am Soc Microbiol
The lung is the primary site of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2)-induced immunopathology whereby the virus enters the host cells by binding to …

Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical …

HR Aghayan, F Salimian, A Abedini… - Stem cell research & …, 2022 - Springer
Background High morbidity and mortality rates of the COVID-19 pandemic have made it a
global health priority. Acute respiratory distress syndrome (ARDS) is one of the most …

Systematic review and meta-analysis of cell therapy for COVID-19: global clinical trial landscape, published safety/efficacy outcomes, cell product manufacturing and …

PS Couto, N Al-Arawe, IS Filgueiras… - Frontiers in …, 2023 - frontiersin.org
During the pandemic of severe respiratory distress syndrome coronavirus 2 (SARS-CoV2),
many novel therapeutic modalities to treat Coronavirus 2019 induced disease (COVID-19) …

Safety of DW-MSC infusion in patients with low clinical risk COVID-19 infection: a randomized, double-blind, placebo-controlled trial

M Karyana, I Djaharuddin, L Rif'ati, M Arif… - Stem cell research & …, 2022 - Springer
Background Due to their immunomodulatory properties, mesenchymal stem cells (MSCs)
have been proposed to have therapeutic potential to improve clinical outcomes in COVID …

Therapeutic role of mesenchymal stem cell-derived exosomes in respiratory disease

MJ Zargar, S Kaviani, M Vasei… - Stem Cell Research & …, 2022 - Springer
Exosomes are extracellular vesicles found in various tissues, blood circulation, and tissue
fluids, secreted into the extracellular environment by fusing a multivesicular body with a …